![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Synergy’s BioSphere Putty Secures Regulatory Clearance in Australia
Synergy’s BioSphere Putty Secures Regulatory Clearance in Australia
![ClearanceStamp_Blue.gif](https://www.fdanews.com/ext/resources/test/Device_Images6/ClearanceStamp_Blue.gif?t=1576043968&width=430)
March 6, 2018
Synergy Biomedical received clearance from Australia’s Therapeutic Goods Administration for its bioactive bone graft product BioSphere Putty.
The product uses spherical bioactive glass particles to create a moldable bone graft putty that improves bone formation.
The product previously received FDA and CE Mark clearances, and has been on the market since 2013.
Upcoming Events
-
21Oct